MDXH
OtherMDxHealth SA
Live · NASDAQ · May 9, Close
What's Moving MDXH Today?
No stock-specific AI insight has been generated for MDXH yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
MDXH News
20 articles- Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 7, 2026
- Tempus AI (TEM) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 5, 2026
- Mdxhealth to Release First Quarter 2026 Financial Results on May 13Yahoo Finance·Apr 30, 2026
- Liquid Biopsy Products Market Report 2026-2031 Featuring Analysis of Roche, Illumina, Qiagen, MDxHealth, Novogen, BGI, Myriad Genetics and MoreYahoo Finance·Mar 20, 2026
- Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026Yahoo Finance·Mar 16, 2026
- MDxHealth S.A. Q4 2025 Earnings Call SummaryMoby·Feb 27, 2026
- MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Rising LossesYahoo Finance·Feb 27, 2026
- MDxHealth (MDXH) Q4 2025 Earnings Call TranscriptMotley Fool·Feb 26, 2026
- MDxHealth Q4 Earnings Call HighlightsMarketbeat·Feb 26, 2026
- Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial ResultsYahoo Finance·Feb 26, 2026
- Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26Yahoo Finance·Feb 12, 2026
- MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact SciencesYahoo Finance·Jan 12, 2026
- Loss-Making MDxHealth SA (NASDAQ:MDXH) Expected To Breakeven In The Medium-TermYahoo Finance·Jan 8, 2026
- MDxHealth announces next phase of collab with University of OxfordYahoo Finance·Jan 7, 2026
- Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancerYahoo Finance·Jan 6, 2026
- European Equities Rise in Tuesday TradingYahoo Finance·Dec 30, 2025
- Sector Update: Health Care Stocks Edge Higher Premarket TuesdayYahoo Finance·Dec 30, 2025
- Institutions profited after MDxHealth SA's (NASDAQ:MDXH) market cap rose US$17m last week but retail investors profited the mostYahoo Finance·Nov 28, 2025
- MDxHealth (MDXH) Q3 2025 Earnings Call TranscriptMotley Fool·Nov 13, 2025
- MDxHealth SA (MDXH) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Acquisitions ...Yahoo Finance·Nov 13, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.